Cite
APA Citation
Augustin, M., McBride, D., Gilloteau, I., O'Neill, C., Neidhardt, K., & Graham, C. N. (2018). cost‐effectiveness of secukinumab as first biologic treatment, compared with other biologics, for moderate to severe psoriasis in Germany. Journal of the European Academy of Dermatology and Venereology, 32, 2191–2199. http://access.bl.uk/ark:/81055/vdc_100073684985.0x000042